Trastuzumab emtansine
Indicated for: breast cancer
Letter T · page 6
Indicated for: breast cancer
Indicated for: glaucoma; ocular hypertension
S01EE04 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Indicated for: glaucoma; ocular hypertension
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: depression
N06AX05 Nervous system | Antidepressants | Other antidepressants
Indicated for: plasma factor replacement; coagulopathy
B02BDN1 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: allergy diagnosis; allergen immunotherapy
Indicated for: cancer; oncologic immunotherapy
Indicated for: cancer
L01AB02 Antineoplastic and immunomodulating agents | Alkylating agents | Alkyl sulfonates
Indicated for: pulmonary arterial hypertension
Indicated for: acne; acute promyelocytic leukemia
Indicated for: inflammation; autoimmune diseases
Indicated for: inflammatory dermatoses
Indicated for: bacterial infections
Indicated for: hemorrhoids; anorectal pain and itching
Indicated for: Wilson disease
Indicated for: acne
Indicated for: cancer
L01BC59 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Indicated for: prevention of atherothrombotic events
Indicated for: Parkinson's disease
N04AA01 Nervous system | Anticholinergic agents | Tertiary amines
Indicated for: gastrointestinal spasms; functional abdominal pain
Indicated for: hemorrhoids; anorectal spasm and pain
Indicated for: angina pectoris
Indicated for: cardiac arrhythmias
Indicated for: prostate cancer; breast cancer; endometriosis
Indicated for: superficial burns; skin irritation; radiodermatitis
Indicated for: metabolic acidosis
Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
Indicated for: nasal congestion; rhinitis
S01FA56 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
Indicated for: overactive bladder; urinary incontinence
Indicated for: chronic venous insufficiency; capillary fragility
C05CA54 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids